Monash University is a public research university based in Melbourne, Victoria, Australia. Named for prominent World War I general Sir John Monash, it was founded in 1958 and is the second oldest university in the state. The university has a number of campuses, four of which are in Victoria, and one in Malaysia.

During the past decade, Monash University conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Monash University" are "Diabetes Mellitus, Type 2" (1 trials) and "Kidney Disease, Chronic" (1 trials). Many other conditions were trialed in "Monash University" in a lesser frequency.

Most popular intervention types in "Monash University" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "BI 456906" (1 trials), "BI 690517" (1 trials), "Empagliflozin" (1 trials), "Placebo" (1 trials) and "Placebo to BI 690517" (1 trials). Other intervention names were less common.

The vast majority of trials in "Monash University" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Monash University". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Monash University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Monash University, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".